Nutrition & Care

Q3 2021

Sales in the Nutrition & Care segment rose considerably compared with the third quarter of 2020. This was due to considerable sales growth in the Care Chemicals division. Sales in the Nutrition & Health division matched the level of the prior-year quarter.

Factors influencing sales in Q3 2021 – Nutrition & Care

 

Nutrition & Care

Care Chemicals

Nutrition & Health

Volumes

7%

10%

2%

Prices

7%

10%

0%

Portfolio

–2%

–2%

–2%

Currencies

0%

0%

0%

Sales

12%

18%

0%

The sales performance was mainly attributable to higher volumes in both divisions. Sales volumes in the Care Chemicals division increased especially in the personal care solutions business and in the home care, industrial and institutional cleaning and industrial formulators business. Volumes in the Nutrition & Health division grew primarily in the pharmaceutical business.

Overall higher price levels contributed to sales growth. Prices rose in the Care Chemicals division, particularly in the oleo surfactants and fatty alcohols business, as well as in the home care, industrial and institutional cleaning and industrial formulators business. Prices in the Nutrition & Health division matched the level of the prior-year quarter.

Portfolio effects from the sale of the production site in Kankakee, ­Illinois, had a negative impact on sales.

The segment’s income from operations (EBIT) before special items was considerably below the level of the prior-year quarter. This was largely due to the significantly lower EBIT before special items in the Nutrition & Health division resulting primarily from lower margins associated with higher raw material and energy prices, which could only be passed on partially. EBIT before special items in the Care Chemicals division decreased slightly due mainly to higher fixed costs.

The decline in special items in the third quarter of 2021 was due primarily to the special charges for impairments and provisions in the prior-year quarter.

Segment data – Nutrition & Care (Million €)

 

Q3

January–September

 

2021

2020

+/–

2021

2020

+/–

Sales to third parties

1,598

1,427

12%

4,715

4,564

3%

of which Care Chemicals

1,108

938

18%

3,250

3,033

7%

Nutrition & Health

490

489

0%

1,465

1,531

–4%

Income from operations before depreciation, amortization and special items

206

247

–17%

761

966

–21%

Income from operations before depreciation and amortization (EBITDA)

207

230

–10%

815

941

–13%

Depreciation and amortizationa

102

144

–29%

301

356

–15%

Income from operations (EBIT)

105

86

22%

514

585

–12%

Special items

1

–57

.

54

–68

.

EBIT before special items

104

143

–27%

460

653

–30%

Assets (September 30)

6,911

6,423

8%

6,911

6,423

8%

Investments including acquisitionsb

196

130

51%

414

336

23%

Research and development expenses

39

41

–5%

122

115

6%

a

Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)

b

Additions to property, plant and equipment and intangible assets